Category: Latest News
-

Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection
Purple Biotech (NASDAQ:PPBT) has received a U.S. patent allowance covering tri-specific antibody constructs and methods of use, expanding intellectual property protection around its modular CAPTN-3 immunotherapy platform as it develops additional oncology candidates. Key Investor Takeaways Why PPBT Stock Is in Focus Purple Biotech has expanded the U.S. intellectual property protection surrounding CAPTN-3, its platform…
-

Vivakor Q3 Revenue Guidance Targets Approximately $270 Million as Supply and Trading Scales
Vivakor (NASDAQ:VIVK) expects its Supply & Trading subsidiary to generate approximately $270 million in unaudited third-quarter revenue, marking a sharp increase from the approximately $40 million generated during the first six months of 2026 as recurring physical crude oil marketing programs scale. Key Investor Takeaways Why VIVK Stock Is in Focus Vivakor has provided Q3…
-

Advasa Adds USDC Payment Functionality to Visa Card and Targets RWA Expansion
Advasa Holdings (NASDAQ:ADBT) has added USDC payment functionality to its existing ADVASA Visa card, expanding its digital payments infrastructure while outlining plans to explore opportunities in the real-world asset tokenization market. Key Investor Takeaways Why ADBT Stock Is in Focus ADVASA is expanding its payment infrastructure by introducing USDC functionality to its existing Visa card.…
-

Palantir U.S. Army TITAN Award Moves AI-Enabled Ground Station Program Into Production
Palantir Technologies (NASDAQ:PLTR) has received a U.S. Army prime agreement to produce and deliver eight new TITAN systems, moving the AI-enabled deep-sensing platform into its next phase following earlier prototype development. Key Investor Takeaways Why PLTR Stock Is in Focus Palantir’s latest Army agreement moves TITAN beyond its earlier prototype phase and into production of…
-

CrowdStrike Expands OpenAI Partnership to Secure Codex Agents and Integrate GPT-5.6 Cyber
CrowdStrike (NASDAQ:CRWD) has expanded its OpenAI partnership to secure Codex agents with Falcon Guardian and bring GPT-5.6 Cyber into the Falcon platform, extending its cybersecurity strategy deeper into enterprise AI deployment and AI-assisted defense. Key Investor Takeaways Why CRWD Stock Is in Focus CrowdStrike is expanding its collaboration with OpenAI around both sides of enterprise…
-

Scorpio Gold Drilling Intersects 3.02 g/t Gold Over 48.92 Metres at Goldwedge
Scorpio Gold (NASDAQ:SGLD) reported new Goldwedge drilling results from its Manhattan District Project in Nevada, including 3.02 g/t gold over 48.92 metres and a separate 99.94-metre interval grading 1.19 g/t gold, adding evidence of both grade and mineralized scale within the target. Key Investor Takeaways Why SGLD Stock Is in Focus Scorpio Gold’s latest Goldwedge…
-

Four Leaf Acquisition and Data443 Advance Business Combination Toward Planned Nasdaq Listing
Four Leaf Acquisition (USOTC:FORL) and Data443 Risk Mitigation (USOTC:ATDS) are advancing their definitive business combination, with preparation of a Form S-4 underway as the companies pursue a Nasdaq listing for the combined business, subject to required approvals and closing conditions. Key Investor Takeaways Why FORL and ATDS Stocks Are in Focus Four Leaf and Data443…
-

Medical Care Technologies Advances Melanoma Scan Beta for AI-Assisted Skin Monitoring
Medical Care Technologies (USOTC:MDCE) is advancing its Melanoma Scan Beta, an AI-assisted imaging platform designed to help users track visible skin changes over time, while the product remains in beta development without regulatory clearance. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is continuing development of Melanoma Scan Beta, positioning the…
-

InterDigital Third Disney Injunction Strengthens European Patent Enforcement Position
InterDigital (NASDAQ:IDCC) has secured a third Disney (NYSE:DIS) injunction from the Unified Patent Court, extending its record of successful patent enforcement against the entertainment group and reinforcing the importance of its video technology licensing portfolio. Key Investor Takeaways Why IDCC Stock Is in Focus InterDigital’s latest Disney injunction adds another favourable ruling to its ongoing…
-

Halozyme Investor Conferences Put ENHANZE and Expanded Drug Delivery Portfolio in Focus
Halozyme (NASDAQ:HALO) will participate in three healthcare investor conferences during September, giving management multiple opportunities to discuss its commercially validated ENHANZE platform and expanding portfolio of drug delivery technologies. Key Investor Takeaways Why HALO Stock Is in Focus Halozyme President and Chief Executive Officer Helen Torley and Chief Financial Officer Darren Snellgrove are scheduled to…